Francesca Carlomagno
- Molecular Biology top 2%
- Endocrinology, Diabetes and Metabolism top 0.5%
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Genetics top 2%
- Co-authors
- Massimo SantoroAlfredo FuscoGiancarlo VecchioRosa Marina MelilloTeresa GuidaGiuliana SalvatoreSuresh AnagantiMichèle Grieco
- Topics
- Cancer-related Molecular Pathways (28 papers)Thyroid Cancer Diagnosis and Treatment (28 papers)HER2/EGFR in Cancer Research (13 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Francesca Carlomagno
88 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Molecular Biology 2.9k
- Endocrinology, Diabetes and Metabolism 2.5k
- Oncology 2.4k
- Pulmonary and Respiratory Medicine 880
- Genetics 823
Countries citing papers authored by Francesca Carlomagno
This map shows the geographic impact of Francesca Carlomagno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Carlomagno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Carlomagno more than expected).
Fields of papers citing papers by Francesca Carlomagno
This network shows the impact of papers produced by Francesca Carlomagno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Carlomagno. The network helps show where Francesca Carlomagno may publish in the future.
Co-authorship network of co-authors of Francesca Carlomagno
This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Carlomagno. A scholar is included among the top collaborators of Francesca Carlomagno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Carlomagno. Francesca Carlomagno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 21 | |
| 5 | 91 | |
| 6 | 11 | |
| 7 | 17 | |
| 8 | 17 | |
| 9 | 53 | |
| 10 | 14 | |
| 11 | 106 | |
| 12 | 136 | |
| 13 | 69 | |
| 14 | 126 | |
| 15 | 54 | |
| 16 | 143 | |
| 17 | 33 | |
| 18 | 51 | |
| 19 | 60 | |
| 20 | 307 |
About Francesca Carlomagno
Francesca Carlomagno is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Hematology, having authored 92 papers that have together received 6.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (28 papers), Thyroid Cancer Diagnosis and Treatment (28 papers) and HER2/EGFR in Cancer Research (13 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.5k citations), Oncology (2.4k citations) and Cancer Research (688 citations). Francesca Carlomagno has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Massimo Santoro, Alfredo Fusco, Massimo Santoro, Giancarlo Vecchio, Rosa Marina Melillo, Teresa Guida, Giuliana Salvatore, Suresh Anaganti, Michèle Grieco and Anderson J. Ryan. Their work appears in journals such as Science, Journal of Biological Chemistry and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.